Thank you, Mr. Chair.
I thank you all for being here.
Mr. Tousaw, on the study that you referred to in Oregon, my understanding of that and some of the other ones in which we're seeing a failure rate in the 20-percentile range is that the 20% includes not a failure of an assessment of impairment but a failure of accurately describing which of the drugs the person used that led to the impairment. Is that correct?
What I'm trying to say to you is that it's a bit disingenuous to say there is an absolute 20% to 25% failure rate. It's not a 20% to 25% failure rate of testing for impairment. It's the type of drug that underlies the impairment.